Cibinetide (ARA 290) regenerates small nerve fibers

New U.S. clinical trial outcomes indicate experimental therapy may not only work against small fiber neuropathy, but also improve chronic fatgue and quality of life in sarcoidosis.

For clinical trial outcomes in study among U.S. sarcoidosis patients, see: http://araimpharma.com/wp-content/uploads/2017/05/ARAIM_DOSARA_Release_05-08-2017.pdf

See also this publication by Dr. Daniel Culver (Cleveland Clinic), which suggests that Cibinetide may improve chronic fatigue and improve quality of life for sarcoidosis patients: https://www.ncbi.nlm.nih.gov/m/pubmed/28475703/

Reageren

Vul je gegevens in of klik op een icoon om in te loggen.

WordPress.com logo

Je reageert onder je WordPress.com account. Log uit / Bijwerken )

Twitter-afbeelding

Je reageert onder je Twitter account. Log uit / Bijwerken )

Facebook foto

Je reageert onder je Facebook account. Log uit / Bijwerken )

Google+ photo

Je reageert onder je Google+ account. Log uit / Bijwerken )

Verbinden met %s